Recent clinical research highlights the transformative role of Carotid Doppler ultrasound in preventive medicine. Many lung cancer screening participants undergo low-dose CT scans to assess pulmonary health. However, these scans also provide a window into cardiovascular status through coronary artery calcification (CAC) scoring. While CAC is a powerful predictor, it does not capture the full spectrum of atherosclerotic risk. Therefore, clinicians are increasingly looking toward carotid imaging to fill these diagnostic gaps.
This prospective study evaluated 250 individuals within a lung cancer screening framework. Researchers aimed to determine how often carotid plaques appear in participants with low or absent coronary calcium. Consequently, they utilized high-resolution ultrasound to detect measurable stenosis. The results suggest that relying solely on CT scans might lead to significant underestimation of a patient’s true cardiovascular burden. Specifically, many patients with low calcium scores still harbor dangerous carotid plaques.
Improving Risk Assessment with Carotid Doppler Ultrasound
The study found that 48.8% of participants overall had measurable carotid plaques. More surprisingly, one-third of the subjects with minimal or no coronary calcification showed evidence of carotid atherosclerosis. These findings are vital because they change how doctors approach preventive therapy. Furthermore, the Carotid Doppler ultrasound findings reclassified several participants as eligible for lipid-lowering treatments like statins. This shift demonstrates that carotid imaging provides unique data that CT scans simply cannot offer.
By integrating ultrasound into screening protocols, medical professionals can achieve a more comprehensive view of subclinical disease. This integrated strategy identifies high-risk individuals who would otherwise remain untreated. Moreover, the procedure is non-invasive and does not involve additional radiation. Clinicians in India, where cardiovascular disease remains a leading health concern, can use this approach to personalize primary prevention. Ultimately, combining these modalities leads to better patient outcomes and more precise therapeutic decisions.
Frequently Asked Questions
Q1: Why should doctors use Carotid Doppler ultrasound alongside lung cancer screening?
Carotid ultrasound identifies subclinical atherosclerosis in patients who have low coronary calcium scores. This helps doctors catch cardiovascular risks that a standard CT scan might miss.
Q2: Can carotid findings change a patient\’s treatment plan?
Yes, finding significant carotid plaques can reclassify a patient as high-risk. This often leads to the initiation of lipid-lowering therapies to prevent future heart attacks or strokes.
Q3: Is this screening method safe for all participants?
The ultrasound procedure is entirely safe, non-invasive, and uses no ionizing radiation. It provides a cost-effective way to enhance the clinical value of existing screening programs.
References
- Mura R et al. Exploring the prevalence and clinical impact of carotid plaque burden by Doppler ultrasound in lung cancer screening participants with limited coronary artery calcification. Eur Radiol. 2026 Feb 24. doi: 10.1007/s00330-026-12390-1. PMID: 41733642.
- Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-188.
- Nasir K et al. Coronary Artery Calcium for Personalized Allocation of Statin Therapy: The MESA Study. J Am Coll Cardiol. 2015 Nov 17;66(20):2201-2209.